Application of tissue-specific NK and NKT cell activity for tumor immunotherapy.
about
Immunology of hepatocellular carcinomaFine tuning a well-oiled machine: Influence of NK1.1 and NKG2D on NKT cell development and functionNatural killer cells in liver diseaseNK cell-based immunotherapy for malignant diseases.Novel molecular, cytotoxical, and immunological study on promising and selective anticancer activity of mung bean sprouts.Immunotherapy for lung cancers.Genomic modeling of tumor onset and progression in a mouse model of aggressive human liver cancer.Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection.Immunoregulation of hepatitis B virus infection--rationale and clinical applicationSelenium nanoparticle-enriched Lactobacillus brevis causes more efficient immune responses in vivo and reduces the liver metastasis in metastatic form of mouse breast cancer.TCR-dependent and -independent activation underlie liver-specific regulation of NKT cells.Advances in cellular therapy for the treatment of thyroid cancer.Cell transfer therapy for cancer: past, present, and future.Human obesity reduces the number of hepatic leptin receptor (ob-R) expressing NK cells.Pivotal roles of ILCs in hepatic diseases.The antitumor effect of the toll-like receptor 3 ligand polyinosinic-cytidylic acid as an adjuvant.IFN-γ production by lung NK cells is critical for the natural resistance to pulmonary metastasis of B16 melanoma in mice.Effect of cytokine-induced killer cells on immune function in patients with lung cancer.Role of lymphocytes in liver cancer.Consequences of TCDD treatment on intra-hepatic lymphocytes during liver regeneration.
P2860
Q26795411-BBFB2DC9-3A6A-443B-87D7-F56786F26D98Q26830239-6BBC3BD0-A421-4763-BEF6-72B1BA07A3AAQ27025451-A1AC0BD3-6572-4CCD-B95C-2F3D430BD991Q33827433-5768EE25-EBDD-4C68-9833-593DB64F7C20Q34465946-AFD44DAB-EAFC-4902-B3B7-70BBA280B0C2Q34557611-AF203DED-D7F4-4522-AD84-B7480C108E62Q35230309-A25CBFD2-80F2-45E8-8456-0AB41A1D87B0Q36326364-781E8DC0-B650-40F3-AF89-88A479188217Q36797085-2B45D063-4DF5-4792-99B9-5794EFA71611Q36858842-E37C46D1-4D21-48F2-95C3-816E50446BDCQ37051132-9F256327-934E-4609-B196-44CDE5C28B9DQ37776660-9E50F730-5A70-453C-87E5-8499F87E0B69Q38205228-F489EF59-9D83-4910-A5AB-5E3C111E6D18Q38331363-310B1572-61EC-49A4-9BB8-429B5008306EQ38366661-591F7D5A-48A2-4BC9-92D1-36991041FC2FQ39301523-51A499DA-5201-4A2F-AAB4-A17A65AFFC5BQ39516441-ED5DE0C0-F79D-4064-BC34-98B9057BA7D3Q39651813-4250CB8F-83D1-4305-8A52-F6713FC7EA02Q42551019-A3437AF0-EE04-4E61-AD90-BD8CD83CD5CBQ53172528-44F312B7-72C2-4167-8CDF-B2FCBF36BD84
P2860
Application of tissue-specific NK and NKT cell activity for tumor immunotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Application of tissue-specific NK and NKT cell activity for tumor immunotherapy.
@en
Application of tissue-specific NK and NKT cell activity for tumor immunotherapy.
@nl
type
label
Application of tissue-specific NK and NKT cell activity for tumor immunotherapy.
@en
Application of tissue-specific NK and NKT cell activity for tumor immunotherapy.
@nl
prefLabel
Application of tissue-specific NK and NKT cell activity for tumor immunotherapy.
@en
Application of tissue-specific NK and NKT cell activity for tumor immunotherapy.
@nl
P2093
P2860
P1476
Application of tissue-specific NK and NKT cell activity for tumor immunotherapy.
@en
P2093
Jeff J Subleski
Jonathan M Weiss
Robert H Wiltrout
P2860
P304
P356
10.1016/J.JAUT.2009.07.010
P577
2009-08-13T00:00:00Z